Navigation Links
Generex Augments Antigen Express Scientific Advisory Board
Date:5/18/2012

erican University of Beirut Medical Center, Beirut, Lebanon.  Upon his emigration to the United States, Dr, Ibrahim completed residencies in Internal Medicine at SUNY Health Science Center, Brooklyn, NY and at St. Luke's-Roosevelt Hospital, New York, NY, and a Postdoctoral Fellowship in Medical Oncology at The University of Texas MD Anderson Cancer Center.

About Generex Biotechnology Corporation

Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device. Antigen Express, Inc. is a wholly owned subsidiary of Generex. The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases. Antigen Express has pioneered the use of specific CD4+ T-helper stimulation in immunotherapy. One of its platform technologies relies on inhibition of expression of the Ii protein. Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T-helper cells and prevents the further growth of cancer cells. For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com.

Cautionary Note Regarding Forward-Looking Statements

This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "f
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
2. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
3. Generex Subsidiary Antigen Express Announces Publication of Review Showcasing its Proprietary Therapeutic Vaccine Technology in the Journal Vaccine
4. Generex Subsidiary Antigen Express to Present at Prestigious Cancer Immunotherapy Summit
5. Generex Subsidiary Antigen Express Featured on SNN Stock News Now; Highlights Advantages of Ii-Key Platform Technology for Cancer Immunotherapy
6. Generex Subsidiary Antigen Express Available for Partnering & Collaboration Meetings at the 2012 JPMorgan Healthcare Conference
7. Generex Announces Airing of Antigen Express Breast Cancer Vaccine Segment on Bloomberg Television
8. Generex Provides Update on Bloomberg TV Breast Cancer Vaccine Segment
9. Generex Subsidiary Antigen Express to Present AE37 Cancer Vaccine Phase 2 Clinical Data at 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium
10. Generex Announces Investor Update Conference Call Planned for Late November
11. Generex to Present at the Rodman & Renshaw 13th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 BD Biosciences, a segment ... ), a leading global medical technology company, today announced the ... the latest in its line of high-performance research flow cytometers. ... high-performance multicolor analysis with the most compact footprint in its ... and a height of 30" (76.2 cm). Recognizing that space ...
(Date:6/19/2013)... WHITE PLAINS, N.Y. , June 19, 2013 /PRNewswire/ ... is supporting more than 300 research projects with one ... patients. And in 2013, "Team In Training" (TNT), a ... largest endurance sports training program, is marking its landmark ... LLS invest more than $875 million in research to ...
(Date:6/19/2013)... 19, 2013 Today MedeAnalytics, a leading ... next-generation of its Employer Group and Individual ... to provide their employer groups an intuitive and ... and prescription drug claims, network utilization, and overall ... ) "Employer Group and Individual ...
Breaking Medicine Technology:New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 2Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 3Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 4Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 5MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2
... Pa., July 28, 2011 West Pharmaceutical Services, Inc. (NYSE: ... the second quarter of 2011.  Summary comparative results were as ... Sales , $ 307.9 , $ 281.8Gross Profit , 84.6 ... (1) , 30.5 , 30.9Reported Diluted EPS ...
... 28, 2011 (Logo: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO)Q2 2011 Change on ... , Constant , exchange rates(1) , H1 2011Change on ... , constant , exchange ratesNet sales , euro 8,349m+0.5% ... euro 2,150m-13.2% , -7.0% , euro 4,320m-11.9% , -11.5%Business ...
Cached Medicine Technology:West Announces Second Quarter 2011 Results 2West Announces Second Quarter 2011 Results 3West Announces Second Quarter 2011 Results 4West Announces Second Quarter 2011 Results 5West Announces Second Quarter 2011 Results 6West Announces Second Quarter 2011 Results 7West Announces Second Quarter 2011 Results 8West Announces Second Quarter 2011 Results 9West Announces Second Quarter 2011 Results 10West Announces Second Quarter 2011 Results 11West Announces Second Quarter 2011 Results 12West Announces Second Quarter 2011 Results 13West Announces Second Quarter 2011 Results 14West Announces Second Quarter 2011 Results 15West Announces Second Quarter 2011 Results 16Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms 2Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms 3Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms 4Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms 5Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms 6Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms 7Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms 8Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms 9Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms 10Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms 11Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms 12Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms 13Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms 14Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms 15Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms 16Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms 17Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms 18Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms 19Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms 20Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms 21
(Date:6/20/2013)... Volume based manufacturing savings have allowed ... retail pricing of both it's WHEY TOO GOOD Vanilla ... Premier Natural Health’s whey protein shake drink ... are formulated to help maintain healthy blood sugar levels, ... the aging process. , Ideal for health conscious ...
(Date:6/20/2013)... Michigan-based natural health and wellness coach Carol ... which revealed that performing random acts of kindness – ... of the feel-good hormone Oxytocin in the brain and ... ‘cardio protective’ hormone because it temporarily lowers blood pressure ... “Being kind is something we can all do, doesn’t ...
(Date:6/20/2013)... (PRWEB) June 20, 2013 Creighton ... Education Community Service Honor Roll – the highest federal ... commitment to volunteering, student- service learning and civic engagement ... presented by the Corporation for National and Community Service, ... sixth for Creighton. “Our foundation at Creighton is based ...
(Date:6/19/2013)... 19, 2013 Paleo Burn has finally been ... finally sculpt the body they desire with no fad diets, ... programs and health food products, Ken Smith was bold enough ... consumers an easy, automatic, and permanent solution for weight loss. ... . , After a quick review of Paleo Burn, TotalWellnessCleanse.net ...
(Date:6/19/2013)... June 19, 2013 Go Classy Tours has ... Resorts for over 25 Years. These resorts, draw ... nude pools, nude bars and nude hot tubs. Grand ... alike. When SuperClubs re-branded the resort to a Breezes ... nude side of the Resort fell off dramatically. "Groups ...
Breaking Medicine News(10 mins):Health News:Premier Natural Health, a Leading Provider of Natural Food Products and Herbal Solutions, Reduces Prices On Its Popular Whey Protein Product 2Health News:Premier Natural Health, a Leading Provider of Natural Food Products and Herbal Solutions, Reduces Prices On Its Popular Whey Protein Product 3Health News:Kindness Can Be Good for The Heart Says BioGirl Health Show 2Health News:Kindness Can Be Good for The Heart Says BioGirl Health Show 3Health News:Creighton Again Named to President’s Honor Roll - University Picks Up Sixth Recognition Award for Service 2Health News:Creighton Again Named to President’s Honor Roll - University Picks Up Sixth Recognition Award for Service 3Health News:Paleo Burn Review Released by TotalWellnessCleanse.net 2Health News:The Former Breezes Resort is Re-Opened by Blue Diamond Resorts as the Original Grand Lido Negril Announced Go Classy Tours 2
... in four men admitted to hospital with acute urinary retention will ... , The risk of death in men after acute urinary retention ... hip. The problem is set to get worse as the population ... sudden inability to pass urine and is often a progression of ...
... Asset Sales and ... Anticipated Pre-Tax Charges ... Va., Nov. 9 Sunrise Senior Living,Inc. (NYSE: SRZ ) today ... 2007. The Company also,provided preliminary information on recapitalizations, asset sales and,anticipated pre- ...
... of chronic hepatitis C and advanced liver disease in ... the disease, a national study in which the Saint ... Patients in the trial who were treated with interferon ... liver inflammation, but the trial unequivocally demonstrated that treatment ...
... benefit from spinal manipulation , , FRIDAY, Nov. 9 ... acute low back pain -- nonsteroidal anti-inflammatory drugs ... patients in a carefully controlled study, Australian researchers ... said, because the evidence for their effectiveness has ...
... Ariz., Nov. 9 Rural/Metro,Corporation (Nasdaq: RURL ) ... quarter ended September 30, 2007 and fiscal 2007 fourth ... opening of markets on November,14, 2007. In conjunction, the ... these results beginning at 9 a.m. (Pacific)/ 11 a.m.,(Eastern). ...
... down due to non-recurring event in 2007, net loss ... in Canadian dollars unless otherwise noted), BELLEVILLE, ON, ... a research-based, technology-driven Canadian,biopharmaceutical company, today announced financial results ... September 30, 2007. "We are also focused on ...
Cached Medicine News:Health News:Study reveals high death toll after severe urinary complications in men over 45 2Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 2Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 3Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 4Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 5Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 6Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 7Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 8Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 9Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 10Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 11Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 12Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 13Health News:Interferon does not slow or stop hepatitis C from worsening, study finds 2Health News:NSAID Drug Therapy Fails to Ease Back Pain 2Health News:Rural/Metro to Host Conference Call to Discuss Results for First Quarter Fiscal 2008 and Fourth Quarter/Fiscal 2007 Year-End 2Health News:Bioniche Reports Fiscal 2008 First Quarter 2Health News:Bioniche Reports Fiscal 2008 First Quarter 3Health News:Bioniche Reports Fiscal 2008 First Quarter 4Health News:Bioniche Reports Fiscal 2008 First Quarter 5Health News:Bioniche Reports Fiscal 2008 First Quarter 6Health News:Bioniche Reports Fiscal 2008 First Quarter 7Health News:Bioniche Reports Fiscal 2008 First Quarter 8Health News:Bioniche Reports Fiscal 2008 First Quarter 9Health News:Bioniche Reports Fiscal 2008 First Quarter 10Health News:Bioniche Reports Fiscal 2008 First Quarter 11
Valin Hemilaminectomy Retractor, self retaining with rack and pinion action....
Scoville-Haverfield Hemilaminectomy Retractor...
Karlin Crank Frame Spinal Retractor Set is designed for posterior lumbar and thoracic spine surgery. Arm design allows the blades be pre-positioned in the wound prior to attachment....
Panther Universal Spinal Retractor System...
Medicine Products: